# A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma

> **NCT00974675** · PHASE1 · TERMINATED · sponsor: **MedImmune LLC** · enrollment: 23 (actual)

## Conditions studied

- Moderate Asthma

## Interventions

- **BIOLOGICAL:** CAT-354 1mg/kg
- **BIOLOGICAL:** CAT-354 5 mg/kg
- **BIOLOGICAL:** CAT-354 10mg/kg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00974675
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09-29
- **Primary completion:** 2007-08-03
- **Final completion:** 2007-08-03
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Study recruitment was terminated before the planned number of subjects was enrolled in CAT-354 10 mg/kg group due to the slow recruitment rate.
- **Last updated:** 2017-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00974675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00974675, "A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00974675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*